Verghese G M, McCormick-Shannon K, Mason R J, Matthay M A
Cardiovascular Research Institute, University of California, San Francisco, California, USA.
Am J Respir Crit Care Med. 1998 Aug;158(2):386-94. doi: 10.1164/ajrccm.158.2.9711111.
Hepatocyte growth factor (HGF) and keratinocyte growth factor (KGF) are among the most potent mitogens identified for alveolar type II epithelial cells and may have other important functions in repair of the alveolar epithelium in acute lung injury (ALI). However, neither growth factor has been identified in the distal air spaces or plasma of patients with ALI. The goals of this study were to determine: (1) whether HGF and KGF are present in pulmonary edema fluid from patients with ALI and control patients with hydrostatic pulmonary edema; (2) whether HGF and KGF are biologically active in pulmonary edema; and (3) whether HGF or KGF levels are associated with clinical outcome. Pulmonary edema and plasma samples were obtained within 48 h of onset of acute pulmonary edema requiring mechanical ventilation in 26 patients with ALI and 11 control patients with hydrostatic edema. HGF and KGF concentrations were measured with enzyme-linked immunosorbent assays (ELISAs). The median (25th to 75th percentiles) concentration of HGF in pulmonary edema fluid was 21.4 (8.3 to 41.3) ng/ml in ALI and 6.6 (4.8 to 11.4) ng/ml in hydrostatic edema fluid (p < 0.01). The HGF concentration was 7-fold higher in the edema fluid than in the plasma of patients with ALI. In contrast, KGF was detected in low concentrations in edema fluid of patients with ALI and hydrostatic pulmonary edema; the concentration of KGF did not differ in ALI edema (0.6 [0.3 to 2.1] ng/ml) and hydrostatic edema fluid (0.2 [0.0 to 2.6] ng/ml) (p = NS). HGF and KGF were partly purified from four edema-fluid samples by heparin-Sepharose chromatography. Partly purified edema fluids were potent stimuli of DNA synthesis in cultured rat type II alveolar cells; addition of neutralizing antibodies to HGF and KGF attenuated this increase in DNA synthesis by 66% and 53%, respectively. Interestingly, higher edema-fluid levels of HGF were associated with higher mortality in patients with ALI. These novel results show that HGF and KGF are active in the alveolar space early in ALI, probably mediating early events in lung repair, and that increased levels of HGF in edema fluid may have prognostic value early in ALI.
肝细胞生长因子(HGF)和角质形成细胞生长因子(KGF)是已确定的对II型肺泡上皮细胞最具活性的促分裂原,在急性肺损伤(ALI)时的肺泡上皮修复中可能具有其他重要功能。然而,在ALI患者的远端气腔或血浆中均未发现这两种生长因子。本研究的目的是确定:(1)HGF和KGF是否存在于ALI患者及静水压性肺水肿对照患者的肺水肿液中;(2)HGF和KGF在肺水肿中是否具有生物活性;(3)HGF或KGF水平是否与临床结局相关。在26例ALI患者和11例静水压性水肿对照患者因急性肺水肿需要机械通气发病后48小时内采集肺水肿和血浆样本。采用酶联免疫吸附测定(ELISA)法检测HGF和KGF浓度。ALI患者肺水肿液中HGF的中位数(第25至75百分位数)浓度为21.4(8.3至41.3)ng/ml,静水压性水肿液中为6.6(4.8至11.4)ng/ml(p<0.01)。ALI患者水肿液中的HGF浓度比血浆高7倍。相比之下,在ALI患者和静水压性肺水肿患者的水肿液中检测到的KGF浓度较低;ALI水肿(0.6[0.3至2.1]ng/ml)和静水压性水肿液(0.2[0.0至2.6]ng/ml)中的KGF浓度无差异(p=无显著性差异)。通过肝素-琼脂糖层析从4份水肿液样本中部分纯化了HGF和KGF。部分纯化的水肿液是培养的大鼠II型肺泡细胞中DNA合成的有效刺激物;加入HGF和KGF的中和抗体分别使DNA合成的增加减弱了66%和53%。有趣的是,ALI患者水肿液中较高的HGF水平与较高的死亡率相关。这些新结果表明,HGF和KGF在ALI早期的肺泡腔中具有活性,可能介导肺修复的早期事件,并且水肿液中HGF水平的升高在ALI早期可能具有预后价值。